Says to me that all is on track.
I am disappointed though in the timing, only because my expectations were for the 90th patient readout to be earlier. I thought the whole dosing trial was to take about three months starting 5 May with say 90 done (around 1/3) by 5 June, then 30 days to endpoint (5 July), then readout and analysis, say late July. What happened? Would have been relevant in the announcement to just give some narrative for the slower start, just to make it a bit more understandable. I feel more comfortable with honesty than the feeling something (probably management or administrative issue) has been swept under the carpet.
That aside, onwards and upwards.
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C, page-76
-
- There are more pages in this discussion • 173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.43 |
Change
0.030(2.15%) |
Mkt cap ! $1.621B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.44 | $1.40 | $1.672M | 1.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29252 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 11195 | 3 |
View Market Depth
| Last trade - 11.00am 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |